Novartis Looks To Take Its Diversity Show On The Road

Company In Early Stages Of International Expansion

Head of clinical trial diversity and inclusion Kim Fookes spoke with Scrip about Novartis’s US trial diversity initiatives and early plans to expand them abroad.

Clinical Research diagram

More from Diversity & Inclusion

More from ESG